Serum Institute of India Pvt. Ltd.
3 clinical trials · 3 recruiting · INDUSTRY
Trials by Serum Institute of India Pvt. Ltd.
RECRUITINGPhase 3NCT06413121
Clinical Study to Assess the Immunogenicity and Safety of Hexavalent Vaccine Containing Reduced Dose IPV
In 2012, the World Health Assembly (WHA) endorsed the proposed Polio Endgame Strategy, which includes withdrawal of the Sabin-virus type 2 antigen-responsible for an estimated 95%...
Sponsor: Serum Institute of India Pvt. Ltd.Enrolling: 15579 locations
Diptheria ImmunizationTetanus ImmunizationPertussis Immunization+3
RECRUITINGNCT07009847
An Observational Study to Assess Effectiveness and Safety of The R21/Matrix-M Malaria Vaccine
This is an observational case-control study to assess the effectiveness of the R21/Matrix-M vaccine against severe malaria, clinical malaria (in high transmission perennial...
Sponsor: Serum Institute of India Pvt. Ltd.Enrolling: 23085 locations
Malaria,FalciparumMorality
RECRUITINGPhase 2NCT07147400
Pfs230D1 + R21 in Matrix-M1 in African School Children and Adults
This is a Phase 2, randomized, double-blind, controlled study designed to evaluate the safety, tolerability, immunogenicity, vaccine efficacy, and functional activity of...
Sponsor: Serum Institute of India Pvt. Ltd.Enrolling: 12001 location
Prevention of Malaria Transmission and Clinical Malaria